// App-Quantinova.ai

: Circulating cell-free methylated DNA (cfmeDNA) to predict postoperative recurrence in patients with muscle-invasive bladder cancer (MIBC).

Researchers

Presenter

  • Pier Vitale Nuzzo

Principal Investigators

  • Sandor Spisak

  • Norbert Solymosi

  • Ankur Chakravarthy

  • Shu Yi Shen

  • Mark Pomerantz

  • Francesco Boccardo

  • Amin Nassar

  • Gwo-Shu Mary Lee

  • Guru Sonpavde

  • Toni K. Choueiri

  • Daniel De Carvalho

  • Matthew L Freedman

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

  • Centre for Bioinformatics, University of Veterinary Medicine Budapest, Hungary, Budapest, Hungary

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Academic Unit of Medical Oncology, IRCCS San Martino University Hospital - IST National Cancer Research Institute, Genoa, Italy

  • Brigham and Women's Hospital, Brookline, MA

  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

Locations

  • United States

  • Hungary

  • Canada

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved